CG Oncology, Inc. Common stock

, including Exhibits 99.1 and 99.2, although it may do so from time to time as its management believes is appropriate or as required by applicable law. Any such

Other Events. On January 9, 2026, the Company announced an expedited timeline for the topline data readout now expected in the first half of 2026 for the Phase

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release, dated January 9, 2026 99.2 Corporate Presentation, dated January 9,